Week 281 Review - Christmas grinched by Optibiotix dip

Although I'm moaning about being down £600 at the end of the week thanks to a 1p drop for OPTI:Optibiotix Health today, it was looking a lot worse early in the week when I was down £5K. The deficit between cost and value has widened to £20,465 and overall portfolio value dropped to £106,617.

There were no big losers this week, but the winners weren't enough to make up for the deficit from a few big shares losing small amounts.

PAY:Paypoint have been one of the more sluggish magic formula shares, but climbed 5% this week to go up by 11% overall. There are a few potential clouds still over this one, but they are making good profits so I remain hopeful they will continue to rise up to my review date in July 2021.

RDT:Rosslyn Data announced a few contract wins, and it looks like their new software for processing customs forms could be a winner. I'm surprised the shares only climbed 5%. It still leaves them down by 65% in my portfolio.

SAE:Simec Atlantis Energy also rose by 5%. I still worry about these and wouldn't buy them now, but I hold in hope.

FXPO:Ferrexpo have been really motoring lately, possibly in anticipation of a January special dividend, and this week they went up 7% to go 62% up overall and making £632 potential profit.

Share of the Week also rose 7%, but I like CAML:Central Asia Metals more, and their rise was worth a lot more thanks to my big holding. These are now 28% up and making £3,041 potential profit. I won't be selling these though. They are a keeper for the epic dividend.

More flatness

The rise seems to have faltered.

Here's the ISA and share portfolios after week 21 of year 6.

			Weekly Change
Cash	£36.70		-£19.25
Portfolio cost	£63,009.29		+£19.25
Portfolio sell value (bid price-commission)	£50,746.95	(-19.5%)	-£894.46
Potential profits	£7,072.05		-£200.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£118.25	(3.4%)	-£5.91
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£340.96	(9.8%)	-£1.22
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Cash went down by £19 as I was allowed to get 11 IES:Invinity Energy shares in the open offer, which is half what I applied for as it was over subscribed. Much better than the 3 I was allocated though. Potential profits are down £200 after JLP:Jubilee Metals lost 0.2p, but given last week's 34% rise I'm amazed the profit takers didn't do more damage. Value is down by a further £694 courtesy of OPTI:Optibiotix Health losing 1p.

I've finally given up on the statistic of monthly performance compared to cost of portfolio. I've decided it's a pointless stat that's going to get harder to live up to as the cost rises and profits are re-invested. I'm now focusing entirely on the performance compared to the injection amount, as that's what I've put into the pot, and what would have been invested in something else. That's still showing I'm way behind 10% target in year 6 when we're almost at the halfway point, but doing ok long-term.

Nasty little dip.

Getting a bit close to the trend line, but still the right side.

Here's the SIPP after week 265 overall and week 5 of year 6.

			Weekly Change
Cash	£468.89		+£0
Portfolio cost	£60,958.91		+£0
Portfolio sell value (bid price - commission)	£53,263.27	(-12.6%)	+£289.92
Potential profits	£4,983.55		+£921.87
Yr 6 Dividends	£346.62		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£0		+£0
Yr 6 Average monthly cash profit	£285.97	(8.6%)	-£71.49
Total Dividends	£2,413.70		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£15,459.44		+£0
Average monthly cash profit	£281.84	(8.5%)	-£1.07
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	43%		+0%

This account improved in value thanks to a socking great £921 increase in potential profits from the likes of CAML:Central Asia Metals and FXPO:Ferrexpo. That made up for the OPTI:Optibiotix Health drop and a bit more. Year 6 performance is still a bit mad as the amount is based on the projection of what we've had in the first 5 weeks, which included the huge CAML dividend. Long term performance still needs a boost, and the only thing that can provide that is if I trade SBTX:SkinBioTherapeutics. In May we'll get a much bigger boost as I start reviewing and selling the magic formula shares.

The increase was so small it looks flat

Still unable to get into that buffer zone.

Here's the trading portfolio after week 231 overall and week 23 of year 5

			Weekly Change
Cash	£241.90		+£0
Portfolio cost	£2,367.55		+£0
Portfolio sell value (bid price - commission)	£1,860.26	(-21.4%)	+£3.55
Potential profits	£0		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£467.10		+£0
Yr 5 Average monthly cash profit	£90.30	(45.8%)	-£4.10
Dividends	£60.10		+£0
Profit from sales	£753.47		+£0
Average monthly cash profit	£15.26	(7.7%)	-£0.07
(Sold stocks profit + Dividends - Fees  / Months)

Couldn't get much more flat really. This one will carry on monitoring performance based on cost, as the cost will never go above around £2,500 unless new £500 increments are made. Key thing is that three of the five stocks are in a position where I may be able to sell them soon, so things could start getting exciting.

I like this chart!

The steep slope is getting steeper.

Here's my wish list:

1. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operation. I'm staggered this hasn't been announced yet, but still we wait.
   
2. OPTI:Optibiotix Health to get within 10% of profit. Second week in a row it has dropped by a penny.
3. CMCL:Caledonia Mining reverses the down trend and gets back into profit. Flat this week. At least it's not a drop. The spread has been stupidly high for a share that also trades on NY Stock Exchange.
   
4.  SBTX:SkinBioTherapeutics gets back into profit. Still falling. Terribly frustrating, but can't go on forever.
5. The combined portfolios get back into the black. A blip downwards this week, but there's some good progress and don't forget I'm sitting on £12,000 un-banked profits at the moment.Normally I'd be cashing these in, but not this time. I'm determined to let them ride.